Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 9, 2025
Accession Number:
0001193125-25-113367
Submission Type:
POS AM
CIK:
0001622229
Company Name:
Cogent Biosciences, Inc.
File Number:
333-264773